Synaptogenix Inc (SNPX)

[blu_1]

Lol It cracks me up how people here put so much faith in subjective data on 3 compassionate use patients over an unknown period of time. And 3 months of data for the Ph 2b patients. If that's credible and rock solid, why should companies even run minimum year long Phase 2 and Phase 3 trials that are expensive? 3 months doesn't tell you efficacy and doesn't tell you side effects. It's not reliable. If it was, people would be calling donepezil the cure for Alzheimers based on 3 month data.

I ask you guys, what causes synapse loss? Does bryostatin correct the causative mechanism of that, or just try to cope with its effects on the back end?